Read the rest here: Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
Original post: Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
More here: New and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be Presented
Go here to see the original: SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium
See more here: ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the...
Read more: Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right...
See the article here: Ascendis Presents Updated and New TransCon™ IL-2 β⁄γ Monotherapy and Combination Therapy Data Confirming Clinical Activity Across Tumor Types...
Link: Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023
Here is the original post: Allogene Therapeutics to Report Third Quarter 2023 Financial Results on November 2, 2023
Recent Comments